Skip to main content

Advertisement

Log in

The relevance of CYSLTR1 gene polymorphism to the severity of allergic rhinitis and clinical responsiveness of montelukast in children

  • Rhinology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Purpose

The etiology of allergic rhinitis (AR) is closely correlated with the complex interactions between genetic and environmental factors. This study explored the effect of single-nucleotide polymorphisms (SNPs) of CYSLTR1 gene on the risk of AR and clinical response to montelukast treatment in children.

Methods

A total of 135 children with AR and 100 healthy children were included for subsequent analyses. Genotype and allele distribution of rs321029 SNP of CYSLTR1 gene and inflammatory mediators were detected and compared between AR and healthy children.

Results

Genotype and allele frequency of rs321029 SNP of CYSLTR1 gene showed no difference between children with AR and controls or between AR cases with different severity. The total montelukast effective rate of wide-type genotype TT children was significantly higher than variants genotype CC children.

Conclusion

Polymorphism of rs321029 on CYSLTR1 gene is not related to the susceptibility and severity of AR in children, but it is closely related with the efficacy of montelukast on AR.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Eifan AO, Durham SR (2016) Pathogenesis of rhinitis. Clin Exp Allergy 46(9):1139–1151. https://doi.org/10.1111/cea.12780

    Article  CAS  PubMed  Google Scholar 

  2. Zhang Y, Zhang L (2014) Prevalence of allergic rhinitis in china. Allergy Asthma Immunol Res 6(2):105–113. https://doi.org/10.4168/aair.2014.6.2.105

    Article  PubMed  Google Scholar 

  3. Nathan RA (2007) The burden of allergic rhinitis. Allergy Asthma Proc 28(1):3–9. https://doi.org/10.2500/aap.2007.28.2934

    Article  PubMed  Google Scholar 

  4. Al Heialy S, McGovern TK, Martin JG (2011) Insights into asthmatic airway remodelling through murine models. Respirology (Carlton, Vic) 16(4):589–597. https://doi.org/10.1111/j.1440-1843.2011.01974.x

    Article  Google Scholar 

  5. Basavarajappa D, Wan M, Lukic A, Steinhilber D, Samuelsson B, Rådmark O (2014) Roles of coactosin-like protein (CLP) and 5-lipoxygenase-activating protein (FLAP) in cellular leukotriene biosynthesis. Proc Natl Acad Sci USA 111(31):11371–11376. https://doi.org/10.1073/pnas.1410983111

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Figueroa DJ, Borish L, Baramki D, Philip G, Austin CP, Evans JF (2003) Expression of cysteinyl leukotriene synthetic and signalling proteins in inflammatory cells in active seasonal allergic rhinitis. Clin Exp Allergy 33(10):1380–1388. https://doi.org/10.1046/j.1365-2222.2003.01786.x

    Article  CAS  PubMed  Google Scholar 

  7. Nayak A (2004) A review of montelukast in the treatment of asthma and allergic rhinitis. Expert Opin Pharmacother 5(3):679–686. https://doi.org/10.1517/14656566.5.3.679

    Article  CAS  PubMed  Google Scholar 

  8. Telleria JJ, Blanco-Quiros A, Varillas D, Armentia A, Fernandez-Carvajal I, Jesus Alonso M, Diez I (2008) ALOX5 promoter genotype and response to montelukast in moderate persistent asthma. Respir Med 102(6):857–861. https://doi.org/10.1016/j.rmed.2008.01.011

    Article  PubMed  Google Scholar 

  9. Asano K, Shiomi T, Hasegawa N, Nakamura H, Kudo H, Matsuzaki T, Hakuno H, Fukunaga K, Suzuki Y, Kanazawa M, Yamaguchi K (2002) Leukotriene C4 synthase gene A(-444)C polymorphism and clinical response to a CYS-LT(1) antagonist, pranlukast. Japanese Patients Moderate Asthma Pharmacogenetics 12(7):565–570. https://doi.org/10.1097/00008571-200210000-00009

    Article  CAS  PubMed  Google Scholar 

  10. Lima JJ, Zhang S, Grant A, Shao L, Tantisira KG, Allayee H, Wang J, Sylvester J, Holbrook J, Wise R, Weiss ST, Barnes K (2006) Influence of leukotriene pathway polymorphisms on response to montelukast in asthma. Am J Respir Crit Care Med 173(4):379–385. https://doi.org/10.1164/rccm.200509-1412OC

    Article  CAS  PubMed  Google Scholar 

  11. Zhang J, Migita O, Koga M, Shibasaki M, Arinami T, Noguchi E (2006) Determination of structure and transcriptional regulation of CYSLTR1 and an association study with asthma and rhinitis. Pediatric Allergy Immunol 17(4):242–249. https://doi.org/10.1111/j.1399-3038.2005.00347.x

    Article  Google Scholar 

  12. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, van Weel C, Agache I, Aït-Khaled N, Bachert C, Blaiss MS, Bonini S, Boulet LP, Bousquet PJ, Camargos P, Carlsen KH, Chen Y, Custovic A, Dahl R, Demoly P, Douagui H, Durham SR, van Wijk RG, Kalayci O, Kaliner MA, Kim YY, Kowalski ML, Kuna P, Le LT, Lemiere C, Li J, Lockey RF, Mavale-Manuel S, Meltzer EO, Mohammad Y, Mullol J, Naclerio R, O’Hehir RE, Ohta K, Ouedraogo S, Palkonen S, Papadopoulos N, Passalacqua G, Pawankar R, Popov TA, Rabe KF, Rosado-Pinto J, Scadding GK, Simons FE, Toskala E, Valovirta E, van Cauwenberge P, Wang DY, Wickman M, Yawn BP, Yorgancioglu A, Yusuf OM, Zar H, Annesi-Maesano I, Bateman ED, Ben Kheder A, Boakye DA, Bouchard J, Burney P, Busse WW, Chan-Yeung M, Chavannes NH, Chuchalin A, Dolen WK, Emuzyte R, Grouse L, Humbert M, Jackson C, Johnston SL, Keith PK, Kemp JP, Klossek JM, Larenas-Linnemann D, Lipworth B, Malo JL, Marshall GD, Naspitz C, Nekam K, Niggemann B, Nizankowska-Mogilnicka E, Okamoto Y, Orru MP, Potter P, Price D, Stoloff SW, Vandenplas O, Viegi G, Williams D (2008) Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 63(Suppl 86):8–160. https://doi.org/10.1111/j.1398-9995.2007.01620.x

    Article  PubMed  Google Scholar 

  13. Busse W, Kraft M (2005) Cysteinyl leukotrienes in allergic inflammation: strategic target for therapy. Chest 127(4):1312–1326. https://doi.org/10.1378/chest.127.4.1312

    Article  CAS  PubMed  Google Scholar 

  14. Shirasaki H, Himi T (2016) Role of cysteinyl leukotrienes in allergic rhinitis. Adv Otorhinolaryngol 77:40–45. https://doi.org/10.1159/000441871

    Article  PubMed  Google Scholar 

  15. Shirasaki H, Kanaizumi E, Watanabe K, Matsui T, Sato J, Narita S, Rautiainen M, Himi T (2002) Expression and localization of the cysteinyl leukotriene 1 receptor in human nasal mucosa. Clin Exp Allergy 32(7):1007–1012. https://doi.org/10.1046/j.1365-2222.2002.01425.x

    Article  CAS  PubMed  Google Scholar 

  16. Kim SH, Ye YM, Hur GY, Lee SK, Sampson AP, Lee HY, Park HS (2007) CysLTR1 promoter polymorphism and requirement for leukotriene receptor antagonist in aspirin-intolerant asthma patients. Pharmacogenomics 8(9):1143–1150. https://doi.org/10.2217/14622416.8.9.1143

    Article  CAS  PubMed  Google Scholar 

  17. Arriba-Mendez S, Sanz C, Isidoro-Garcia M, Davild I, Laffond E, Horeno E, Avila C, Lorente F (2006) 927T>C polymorphism of the cysteinyl-leukotriene type-1 receptor (CYSLTR1) gene in children with asthma and atopic dermatitis. Pediatric Allergy Immunol 17(5):323–328. https://doi.org/10.1111/j.1399-3038.2006.00416.x

    Article  Google Scholar 

  18. Kim SH, Oh JM, Kim YS, Palmer LJ, Suh CH, Nahm DH, Park HS (2006) Cysteinyl leukotriene receptor 1 promoter polymorphism is associated with aspirin-intolerant asthma in males. Clin Exp Allergy 36(4):433–439. https://doi.org/10.1111/j.1365-2222.2006.02457.x

    Article  CAS  PubMed  Google Scholar 

  19. Peters-Golden M, Gleason MM, Togias A (2006) Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis. Clinical Exp Allergy 36(6):689–703. https://doi.org/10.1111/j.1365-2222.2006.02498.x

    Article  CAS  Google Scholar 

Download references

Funding

No source of funding.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed significantly to the work, have seen and approved the manuscript.

Corresponding authors

Correspondence to Hao Li or Hui Li.

Ethics declarations

Conflict of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Ethics approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the Shandong Provincial Hospital Affiliated to Shandong First Medical University.

Consent to participate/publication

Informed consent was obtained from all the children' parents for both participation and publication of the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhao, M., Li, H. & Li, H. The relevance of CYSLTR1 gene polymorphism to the severity of allergic rhinitis and clinical responsiveness of montelukast in children. Eur Arch Otorhinolaryngol 278, 4847–4853 (2021). https://doi.org/10.1007/s00405-021-06771-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-021-06771-z

Keywords

Navigation